The Fabrication And Evaluation of the Formulation Variables of a Controlled-Porosity Osmotic Drug Delivery System with Diltiazem Hydrochloride

Pundarikakshudu,Kilambi;

News

Article

September 2, 2003

Pharmaceutical Technology

Pharmaceutical Technology-09-02-2003

Volume27

Issue 9

The Fabrication And Evaluation of the Formulation Variables of a Controlled-Porosity Osmotic Drug Delivery System with Diltiazem Hydrochloride

Author(s):

Kilambi Pundarikakshudu, PhD

The study presented in this article used a controlled-porosity osmotic pump, which was prepared in the form of a bilayered tablet containing a drug compartment and an osmogen layer for the delayed release of diltiazem HCI.

External Link - article-70094.pdf

Articles in this issue

September 2003

In the Spotlight September 2003

Counterfeiting, Compliance, and Controls

September 2003

The Fabrication And Evaluation of the Formulation Variables of a Controlled-Porosity Osmotic Drug Delivery System with Diltiazem Hydrochloride

Disposable Filtration Lightens Cleaning and Validation Load

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!